STANDARD TREATMENT OF BRAIN CANCER

Brain cancer encompasses a range of tumours originating in the brain, with glioblastoma multiforme (GBM) being the most aggressive and prevalent malignant form in adults.


There are approximately 16% of all primary brain tumours, GBM poses significant challenges due to its rapid progression and resistance to conventional treatments therefore, we highly recommend if patient has such cancer to go rather with our new method where survival time post-diagnosis is approximately 5 years, with about 24% of patients surviving beyond five years.


In Europe in the United Kingdom the incidence of GBM varies, with estimates ranging from 3.26 to 4.52 cases per 100,000 person yearly. While in the United States, there is over 14,000 new cases yearly.

The disease is slightly more common in men than in women.


Standard treatments for brain cancer in Europe and in the United Kingdom are designed to remove or destroy tumour cells while preserving neurological function. These approaches often involve a combination of surgery, radiation therapy, and chemotherapy tailored to the individual patient's condition.


Each of these brain cancer treatment options has its own advantages and disadvantages, and the choice of therapy depends on various factors, including the type, size, and location of the tumour, as well as the patient's overall health.

Book Your Brain Cacner Standard Treatment Here

STANDARD PROCEDURES IN EUROPE AND IN THE UNITED KINGDOM

SURGICAL PROCEDURE

RADIOTHERAPY

CHEMOTHERAPY

Surgical intervention is typically the first basic step in treating brain tumours, especially when the tumour is accessible and operable.


A craniotomy involves removing a portion of the skull to access the brain and excise the tumour.

The goal is to remove as much of the tumour as possible while ensuring patient safety, which can alleviate symptoms and improve the effectiveness of subsequent treatments.


However, complete removal may not be feasible if the tumour is located near critical brain regions.

Radiotherapy uses high-energy beams, such as X-rays or protons, to target and kill cancer cells. External beam radiation is the most common form, in which the radiation is directed at the tumour from outside the body.


This treatment can be used post-surgery to eliminate any remaining cancer cells or as a primary treatment when surgery is not an option.


Proton therapy is an advanced form of radiation that uses protons instead of X-rays. This method allows for more precise tumour targeting, minimizing damage to surrounding healthy tissue. It is particularly beneficial for treating tumours located near sensitive areas of the brain and is associated with fewer side effects compared to traditional radiation therapy.

Chemotherapy involves the use of drugs to destroy cancer cells.


It is often combined with surgery and radiotherapy.


Although chemotherapy can be effective, it may cause side effects such as nausea, fatigue, and an increased susceptibility to infections.




All these 3 standard brain cancer treatment options has its own advantages and limitations, and the choice of therapy depends on the type, size, and location of the tumour, as well as the patient's overall health.

NEUROENDOCRINE TUMOURS (NETs)

This is paragraph text. Click it or hit the Manage Text button to change the font, color, size, format, and more. To set up site-wide paragraph and title styles, go to Site Theme.

This is paragraph text. Click it or hit the Manage Text button to change the font, color, size, format, and more. To set up site-wide paragraph and title styles, go to Site Theme.

This is paragraph text. Click it or hit the Manage Text button to change the font, color, size, format, and more. To set up site-wide paragraph and title styles, go to Site Theme.

The above: BRAIN CANCER DATA Period 2019 -2024 > Hospital Trials and Treatment with our NEW Medication and treatment.

See full details at Brain Tumour treatment, new medication based on DNA by Zdenko Kos


UPC: 3901030000330010

Brand: MARAGEANDON COMBINED TREATMENT

Country of Product Origin: GERMANY | SWITZERLAND

Ean Code: 6606834200066

Safety Warnings: CONSULTANT WILL EXPLAIN THE DETAILS BEFORE THE TREATMENT

Allergy Advice: CONSULTANT WILL EXPLAIN THE DETAILS BEFORE THE TREATMENT

Course Time: ONE (1) YEAR UP TO FIVE (5) YEARS

Storage: WILL BE STORED BY THE HOSPITAL

Lifestyle: COURSE TIME DEPEND ON PATIENT 'S CANCER STATUS

Price Dependence: YES

Supplier: THE KOS FOUNDATION


ABOUT MARAGEANDON COMBINED TREATMENT

Your health is our priority and your most valuable asset. Marageandon (registered under different name) is currently the top medication/ treatment prepared in Swiss labs of Zdenko Kos Foundation and manufactured by the German pharmaceutical giant. Approved by EMA.

By Buying/ Booking this package you are getting as follows:


  1. A dedicated doctor, consultant and coordinator available 24/7/365
  2. Pre-treatment consultations with world-class oncologists, neurologists, neurosurgeons, plastic surgeons and other medical professionals
  3. In-depth analysis of your medical history and imaging
  4. Preparation and submission of medical documents
  5. Development of a personalized care plan with innovative treatment options on DNA basis
  6. Ongoing support during your hospital stays
  7. Coordination of follow-up care in your home country
  8. Selection and choice of the most suitable clinic and specialist
  9. Full assistance with travel, visas, and accommodation
  10. Transparent pricing with no hidden fees with full insurance.


IMPORTANT INFORMATION

Treatment will be undergoing and completed at public hospital or private local hospital under the doctors and staff from that particular hospital and under additional supervision of doctors directed by the Z KOS Foundation and German manufacturer.

Choose our treatment abroad and rest assured you will get the best treatment money can buy!


LEGAL DISCLAIMER

Depend on level of your disease, we are strictly recommending 2-3 years. 5 years treatment recommended only on very complicated cases and in the last level of dieses. If in meantime the Z KOS Foundation and manufacturer finds another breakthrough version of improved medication the treatment will be carried out with that new medications. Additional charges might applies.


TREATMANTS AVAILABLE:

  1. One (1) Year Hospital Treatment: £15,000.00
  2. Two (2) Years Hospital Treatment: £22,400.00
  3. Three (3) Years Hospital Treatment: £31,800.00
  4. Five (5) Years Hospital Treatment: £44,200.00

The above figures represent ¼ of original costs because The Zdenko Kos Foundation contribute and cover the balance of ¾ of the real price.


HOSPITALS AVAILABILITY:

  1. At German Public Hospital: £1,440.00 per 1 year
  2. At German Private Hospital: £6,000.00 per 1 year
  3. At Italian Public Hospital: £1,680.00 per 1 year
  4. At Italian Private Hospital: £8,640.00 per 1 year
  5. At Swiss Public Hospital: £2,520.00 per 1 year
  6. At Swiss Private Hospital: £10,560.00 per 1 year


List of hospital will be presented to you by Consultant at the first appointment when you will have complete check-up.

All prices listed above are from December 2024 and valid till December 2025.